HDAC6 and neoplasm: However, the specific regulatory mechanism of HDAC6 on PD-L1 is not clear, and whether ACY-1215 can improve the therapeutic effect of anti-PD1/PD-L1 and its function in anti-tumor immunity need to be further clarified.